Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
June 01, 2021 15:49 ET | Source: Cognos Therapeutics Corp. Cognos Therapeutics Corp. Inglewood, California, UNITED STATES
INGLEWOOD, Calif., June 01, 2021 (GLOBE NEWSWIRE) via InvestorWire Cognos Therapeutics Corp. (“Cognos”, the Company”), an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, announces today that it has signed a Letter of Engagement to retain Maxim Group LLC (“Maxim”) to provide financial advisory and investment banking services, including to assist in identifying and evaluating targeted M&A opportunities.
“We are incredibly pleased to launch this relationship with Maxim,” stated Frank Adell, CEO of Cognos. “We believe Maxim can assist us in pursuing strategic growth and in building long-term
/PRNewswire/ CP Group, formerly Crocker Partners, today announced the acquisition of a three-building portfolio from Franklin Street Properties Corp. in a.
Additional local business closings to occur later this year LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has successfully completed the
Northern Dynasty: US Army Corps of Engineers finalizes Administrative Record for Pebble Project appeal tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.